{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T04:21:01Z","timestamp":1787458861139,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04309-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:38:31Z","timestamp":1773851911000},"page":"3931-3940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic \u0131mpact of the modified Ryan tumor regression score in gastric and GEJ adenocarcinomas treated with neoadjuvant FLOT regimen"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-6827","authenticated-orcid":false,"given":"Mehmet Akif","family":"Parlar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efnan","family":"Alg\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6znur","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Sekmek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali Nahit","family":"\u015eendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"3","key":"4309_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4309_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0555","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0555.","journal-title":"N Engl J Med"},{"issue":"11","key":"4309_CR3","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680\u20136. https:\/\/doi.org\/10.1002\/1097-0142(19940601)73:11%3c2680::aid-cncr2820731105%3e3.0.co;2-c.","journal-title":"Cancer"},{"issue":"2","key":"4309_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00428-017-2232-x","volume":"472","author":"R Langer","year":"2018","unstructured":"Langer R, Becker K. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy. Virchows Arch. 2018;472(2):175\u201386.","journal-title":"Virchows Arch"},{"key":"4309_CR5","unstructured":"College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the esophagus. Available from: https:\/\/documents.cap.org\/protocols\/cp-giupper-esophagus-20-4100.pdf. 2020. Accessed 9 Oct 2020"},{"issue":"2","key":"4309_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","volume":"47","author":"R Ryan","year":"2005","unstructured":"Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141\u20136. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02176.x.","journal-title":"Histopathology"},{"issue":"7","key":"4309_CR7","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/cncr.11660","volume":"98","author":"K Becker","year":"2003","unstructured":"Becker K, Mueller JD, Schulmacher C, Ott K, Fink U, Busch R, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98(7):1521\u201330. https:\/\/doi.org\/10.1002\/cncr.11660.","journal-title":"Cancer"},{"issue":"8","key":"4309_CR8","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.ejso.2020.12.010","volume":"47","author":"M Hayashi","year":"2021","unstructured":"Hayashi M, Fujita T, Matsushita H. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric\/gastroesophageal adenocarcinoma: a meta-analysis of 14 published studies. Eur J Surg Oncol. 2021;47(8):1996\u20132003. https:\/\/doi.org\/10.1016\/j.ejso.2020.12.010.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"4309_CR9","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.4251\/wjgo.v13.i12.2161","volume":"13","author":"ZN Liu","year":"2021","unstructured":"Liu ZN, Wang YK, Zhang L, Jia YN, Fei S, Ying XJ, et al. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy. World J Gastrointest Oncol. 2021;13(12):2161\u201379. https:\/\/doi.org\/10.4251\/wjgo.v13.i12.2161.","journal-title":"World J Gastrointest Oncol"},{"key":"4309_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.587856","volume":"11","author":"JW Xie","year":"2021","unstructured":"Xie JW, Lu J, Xu BB, Zheng CH, Li P, Wang JB, et al. Prognostic value of tumor regression grading in patients treated with neoadjuvant chemotherapy plus surgery for gastric cancer. Front Oncol. 2021;11:587856. https:\/\/doi.org\/10.3389\/fonc.2021.587856.","journal-title":"Front Oncol"},{"issue":"13","key":"4309_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouch\u00e9 O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321. https:\/\/doi.org\/10.1200\/JCO.2010.33.0597.","journal-title":"J Clin Oncol"},{"issue":"10184","key":"4309_CR12","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557.","journal-title":"Lancet"},{"issue":"4","key":"4309_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4103\/ijc.IJC_1283_20","volume":"61","author":"MM Atci","year":"2024","unstructured":"Atci MM, Secmeler S, Sakin A, Arici S, Can O, Selvi O, et al. Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome. Indian J Cancer. 2024;61(4):714\u201321. https:\/\/doi.org\/10.4103\/ijc.IJC_1283_20.","journal-title":"Indian J Cancer"},{"issue":"1","key":"4309_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41591-023-02660","volume":"30","author":"JS Deutsch","year":"2024","unstructured":"Deutsch JS, Cimino-Mathews A, Thompson E, et al. Association between pathologic response and survival after neoadjuvant therapy in lung cancer. Nat Med. 2024;30(1):218\u201328. https:\/\/doi.org\/10.1038\/s41591-023-02660.","journal-title":"Nat Med"},{"issue":"9938","key":"4309_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8.","journal-title":"Lancet"},{"issue":"19","key":"4309_CR16","doi-asserted-by":"publisher","first-page":"19633","DOI":"10.1002\/cam4.6597","volume":"12","author":"H Yin","year":"2023","unstructured":"Yin H, Yao Q, Xie Y, Niu D, Jiang W, Cao H, et al. Tumor regression grade combined with post-therapy lymph node status: a novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma. Cancer Med. 2023;12(19):19633\u201343. https:\/\/doi.org\/10.1002\/cam4.6597.","journal-title":"Cancer Med"},{"issue":"18","key":"4309_CR17","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/cancers13184676","volume":"13","author":"E Lieto","year":"2021","unstructured":"Lieto E, Auricchio A, Tirino G, Pompella L, Panarese I, Del Sorbo G, et al. Naples prognostic score predicts tumor regression grade in resectable gastric cancer treated with preoperative chemotherapy. Cancers (Basel). 2021;13(18):4676. https:\/\/doi.org\/10.3390\/cancers13184676.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"4309_CR18","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i6.106517","volume":"17","author":"N Bulut","year":"2025","unstructured":"Bulut N, Erdem GU, Kapagan T, Erol VB, Sahin T, Yakin M, et al. Prognostic impact of histopathological features and serum inflammatory markers in patients with gastric cancer undergoing neoadjuvant therapy. World J Gastrointest Surg. 2025;17(6):106517. https:\/\/doi.org\/10.4240\/wjgs.v17.i6.106517.","journal-title":"World J Gastrointest Surg"},{"issue":"3","key":"4309_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2503701","volume":"393","author":"YY Janjigian","year":"2025","unstructured":"Janjigian YY, Al-Batran SE, Wainberg ZA, Muro K, Molena D, Van Cutsem E, et al. Perioperative durvalumab in gastric and gastroesophageal junction cancer. N Engl J Med. 2025;393(3):217\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2503701.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04309-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:20:30Z","timestamp":1787455230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04309-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["4309"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04309-5","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of \u0131nterest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Ankara Bilkent City Hospital (approval date: September 27, 2025; decision number: 25-1612). Due to its retrospective design, the requirement for informed consent was waived by the ethics committee. All procedures were conducted in accordance with the Declaration of Helsinki and national ethical standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, the requirement for informed consent was waived.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}